Related by context. Frequent words. (Click for all words.) 77 Initiates Phase II 76 Initiate Phase 73 Commences Phase 73 Phase Ib II 72 Pivotal Phase III 72 Meets Primary Endpoint 72 Presents Positive 71 Initiates Phase 71 Completes Enrollment 70 Pivotal Phase 70 phase Ib 69 phase IIa clinical 69 Receives Orphan Drug Designation 69 Phase III Clinical Trial 69 Phase Ib clinical 69 forodesine 69 phase IIb clinical 68 Pivotal Study 68 multicenter Phase 68 phase IIa 67 AEG# 67 Tesetaxel 67 GVAX R 67 Inc Therapeutic Competitors 67 deforolimus 66 refractory chronic lymphocytic 66 NASDAQ LGND 66 ThermoDox R 66 Phase 1b clinical 66 Amrubicin 66 IIa trial 66 Factor VIIa 66 NASDAQ SCLN 66 Daclizumab 66 R sorafenib tablets 66 liposomal formulation 66 Clinical Trial Results 66 MKC# 66 submitted Biologics License 66 Phase IIB 66 Panzem R 65 Genaera Corporation 65 Inc. NASDAQ MRNA 65 PEG SN# 65 Patient Enrollment 65 Phase III Trial 65 Drug Candidate 65 Metastatic Melanoma 65 Bicifadine 65 See BioWorld Today 65 Pivotal Trial 65 Alzhemed TM 65 metastatic hormone refractory 65 THALOMID 65 Inc. Nasdaq VVUS 65 elotuzumab 65 ImmunoCellular Therapeutics 65 Phase IIIb 65 ongoing Phase 1b 64 Clinical Trials Update 64 Epratuzumab 64 Inc. Nasdaq IMGN 64 PLK1 SNALP 64 Æterna Zentaris 64 Phase IIb trials 64 Nasdaq VRTX 64 AMD# [002] 64 GRNVAC1 64 Inc. Nasdaq SEPR 64 HGS ETR2 64 sunitinib malate 64 SAR# [004] 64 Nasdaq REGN 64 FDA Accepts 64 gets USFDA nod 64 Phase 2a clinical 64 Nasdaq ENZN 64 Idera Pharmaceuticals 64 II Clinical Trial 64 phase IIb 64 placebo controlled Phase 64 Shigamabs ® 64 Argatroban 64 phase 2a 64 Cyclacel Pharmaceuticals 63 registrational trial 63 Phase 1b trial 63 polymerase inhibitor 63 Single Dose 63 ALN TTR 63 Application MAA 63 confirmatory Phase III 63 NASDAQ DYAX 63 proteasome inhibitor 63 TARRYTOWN NY BUSINESS WIRE 63 RH1 63 advanced carcinoid 63 multiple myeloma MM 63 Pharmos Corporation 63 Halozyme Therapeutics 63 NEBIDO R